Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing[...]

In the context of the PRAISE e-cohort, we listed here scientific articles about OASI. This list is regularly updated.
Last update: January 29th, 2020
- Dec 9, 2019
Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy
- Oct 4, 2019
Testing Immune-Related Adverse Events in Cancer Immunotherapy
- Aug 15, 2019
Balancing cancer immunotherapy and immune-related adverse events: The emerging role [...]
- Jul 3, 2019
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard [...]
- Jun 13, 2019
Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- Jan 24, 2019
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with RA
- Jan 18, 2019
Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?
- Aug 20, 2018
Impact of Baseline Steroids on Efficacy of Programmed CellDeath-1 and Programmed Death-Ligand 1 ...
- Jun 28, 2018
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-Review From the Mela [...]
- Jun 1, 2018
Cost of inpatient admissions for immune-related adverse effects from immune checkpoint [...]
- Mar 10, 2018
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- Mar 1, 2018
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer
- Feb 14, 2018
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint [...]
- Jan 11, 2018
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- Oct 10, 2017
Clinical features, predictive correlates, and pathophysiology of immune-related adverse events[...]
- Jun 9, 2017
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor [...]
- Feb 15, 2017
Opportunistic autoimmunity secondary to cancer immunotherapy(OASI): An emerging challenge
- Dec 1, 2016
Neurologic complications of immune checkpoint inhibitors
- Oct 24, 2016
The Safety of Therapeutic Monoclonal Antibodies: Implications for Cancer Therapy [...]